Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Prior research has shown that helminth infection induces both innate and adaptive immune responses.
Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID.
People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.
The findings provide a basis for future studies of the immune system’s role in longevity.
NIH-funded study suggests need to boost CD8+ T cell response after infection.
The condition may be caused by hidden viral reservoirs that remain in the body after initial infection.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.
Researchers are the first to link COVID-specific T cells to lung function and long COVID.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.